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CORRESPONDENCE
Letter to the Editor
Presence of Evolutionary Pressures or Genotyping Error
Mostafa Saadat
Department of Biology, College of Sciences, Shiraz University, Shiraz, Iran
I have read with great interest the recent study by Ryu et al., which 
is published in the Journal of Korean Medical Science (1). The 
authors investigated the possible association between genetic 
polymorphisms in XRCC1 at codons 194 (rs. 1799782) and 399 
(rs. 25487) and the risk of papillary thyroid carcinoma in a Korean 
sample. They found that there was no significant association 
between these polymorphisms and the susceptibility to papil-
lary thyroid carcinoma. I would like to make a few comments 
about the study. 
  The authors mentioned the prevalence of genotypes among 
controls did not deviate from Hardy-Weinberg equilibrium 
(HWE) (1). However, based on data presented in Table 2 of the 
study of Ryu et al., I found that for the Arg399Gln polymorphism 
of XRCC1, there was a large difference between expected and 
observed frequencies for the genotypes (χ2 = 13.684, df = 1, P =  
0.0002). In the presence of evolutionary pressure, or nonran-
dom mating, statistically significant deviation from the HWE 
might be observed. It should be noted that the deviation from 
HWE may be a sign of genotyping error (2).
  Although I am not familiar with population genetics of Kore-
an populations, according to previous reports I understand that 
among Asian populations (including Korean population), the 
prevalence of the Gln399 allele is about 0.30 (3-5). But the fre-
quency of Gln399 allele was reported 0.185 by Ryu and his co-
workers (1). Based on my search, there is no study describing 
the association between the Arg399Gln polymorphism and evo-
lutionary pressures among general population. Taken together, 
I think that the above mentioned deviation from HWE was ob-
served because of some kind of genotyping error(s). Therefore 
the results of Ryu et al. (1) should be interpreted with caution.
  Finally, considering that these two SNPs are closely linked 
loci, the authors should have used one of the available software’s 
for haplotype analysis. 
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